Incidence of antiplatelet factor 4/heparin antibody induction in patients undergoing percutaneous coronary revascularization

American Journal of Cardiology

Volumn 95, Issue 6, 2005, Pages 744-747

  Gluckman, Tyler J ^b   Segal, Jodi B ^b   Fredde, Natalie L ^b   Saland, Kenneth E ^b   Jani, Jayesh T ^b   Walenga, Jeanine M ^b   Prechel, M Margaret ^b   Citro, Kathleen M ^b   Zidar, David A ^b   Fox, Emily ^b   Schulman, Steven P ^b   Kickler, Thomas S ^b   Rade, Jeffrey J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONIST; ANTIBODY; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HEPARIN ANTIBODY; PROTEIN INHIBITOR; RECEPTOR; THROMBOCYTE FACTOR 4; THROMBOCYTE FACTOR 4 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EXPOSURE; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN INDUCTION; SEROTONIN RELEASE; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 20044372522     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.11.026     Document Type: Article

References (20)

1. T. Warkentin, J.G. Kelton A 14-year study of heparin-induced thrombocytopenia Am J Med 101 1996 502 507
2. D.B. Cines, A. Tomaski, S. Tannenbaum Immune endothelial-cell injury in heparin-associated thrombocytopenia N Engl J Med 316 1987 581 589
3. C. Pouplard, S. Iochmann, B. Renard, O. Herault, P. Colombat, J. Amiral, Y. Gruel Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia Blood 97 2001 3300 3302
4. G.M. Arepally, I.M. Mayer Antibodies from patients with heparin-induced thrombocytopenia stimulate monocytic cells to express tissue factor and secrete interleukin-8 Blood 98 2001 1252 1254
5. A.V. Mattioli, L. Bonetti, S. Sternieri, G. Mattioli Heparin-induced thrombocytopenia in patients treated with unfractionated heparin: prevalence of thrombosis in a 1 year follow-up Ital Heart J 1 2000 39 42
6. R.T. Williams, L.V. Damaraju, M.A. Mascelli, E.S. Barnathan, R.M. Califf, M.L. Simoons, E.N. Deliargyris, D.C. Sane Anti-platelet factor 4/heparin antibodies: an independent predictor of 30-day myocardial infarction after acute coronary ischemic syndromes Circulation 107 2003 2307 2312
7. B.J. Woodhams, M. Grimaux Detection of PF4-heparin auto-antibodies by ELISA Thromb Haemost 82 1999 157 158
8. D. Sheridan, C. Carter, J.G. Kelton A diagnostic test for heparin-induced thrombocytopenia Blood 67 1986 27 30
9. T.E. Warkentin, J.G. Kelton Temporal aspects of heparin-induced thrombocytopenia N Engl J Med 344 2001 1286 1292
10. R.H. Hongo, B.N. Brent Association of eptifibatide and acute profound thrombocytopenia Am J Cardiol 88 2001 428 431
11. T.E. Warkentin, M.N. Levine, J. Hirsh, P. Horsewood, R.S. Roberts, M. Gent, J.G. Kelton Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin N Engl J Med 332 1995 1330 1335
12. E. Lindhoff-Last, R. Nakov, F. Misselwitz, H.K. Breddin, R. Bauersachs Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated or low-molecular-weight heparin Br J Haematol 118 2002 1137 1142
13. J. Amiral, A. Marfaing-Koka, M. Wolf, M.C. Alessi, B. Tardy, C. Boyer-Neumann, A.M. Vissac, E. Fressinaud, M. Poncz, D. Meyer Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia Blood 88 1996 410 416
14. J. Amiral Antigens involved in heparin-induced thrombocytopenia Semin Hematol 36 1999 7 11
15. B.H. Chong, J. Burgess, F. Ismail The clinical usefulness of the platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia Thromb Haemost 69 1993 344 350
16. J.G. Kelton, D. Sheridan, A. Santos, J. Smith, K. Steeves, C. Smith, C. Brown, W.G. Murphy Heparin-induced thrombocytopenia: laboratory studies Blood 72 1988 925 930
17. W.P. Jeske, J.M. Walenga, E. Szatkowski, M. Ero, J.M. Herbert, S. Haas, M. Bakhos Effect of glycoprotein IIb/IIIa antagonists on the HIT serum induced activation of platelets Thromb Res 88 1997 271 281
18. S. Haas, J.M. Walenga, W.P. Jeske, J. Fareed Heparin-induced thrombocytopenia: the role of platelet activation and therapeutic implications Semin Thromb Hemost 25 suppl 1 1999 67 75
19. T. Warkentin Clinical presentation of heparin-induced thrombocytopenia Semin Hematol 35 1998 9 16
20. J. Polgar, P. Eichler, A. Greinacher, K.J. Clemetson Adenosine diphosphate (ADP) and ADP receptor play a major role in platelet activation/aggregation induced by sera from heparin-induced thrombocytopenia patients Blood 91 1998 549 554